Suppr超能文献

高、低分子量肝素在体外均不改变红细胞的聚集性。

High and low molecular weight heparins do not modify red blood cell aggregability in vitro.

作者信息

Martínez M, Vaya A, López-Camacho C, Coll-Sangrona E, Mira Y, Aznar J

机构信息

Department of Clinical Pathology, University La Fe Hospital, Valencia, Spain.

出版信息

Clin Hemorheol Microcirc. 2000;23(1):67-70.

Abstract

The usefulness of heparins as anticoagulants has been demonstrated, but their effects on hemorheological parameters, such as erythrocyte aggregability, are under discussion. If the heparins had adverse effect on erythrocyte aggregability, its use would be especially undesirable in patients with pathologies involving red blood cell hyperaggregability as is the case of cardiac disease. In the present study we examine the in vitro effect of unfractionated and fractionated heparins on red blood cell aggregability. The results show that heparins do not increase this rheological parameter but show a slight tendency to lower it.

摘要

肝素作为抗凝剂的效用已得到证实,但其对血液流变学参数(如红细胞聚集性)的影响仍在讨论中。如果肝素对红细胞聚集性有不利影响,那么在患有涉及红细胞高聚集性的疾病(如心脏病)的患者中使用肝素就尤其不可取。在本研究中,我们检测了普通肝素和低分子肝素对红细胞聚集性的体外作用。结果表明,肝素不会增加这一血液流变学参数,反而有轻微降低它的趋势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验